GridAI Technologies (GRDX) Dividends payables (2020 - 2025)
GridAI Technologies' (GRDX) quarterly Dividends payables came in at $337240.0 in Q4 2025, down 74.27% YoY from $1.3 million in Q4 2024, and down 78.45% on a QoQ basis from $1.6 million in Q3 2025.
GridAI Technologies (GRDX) Dividends payables (2020 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 6 years of Dividends payables data on file, last reported at $337240.0 in Q4 2025.
- Quarterly Dividends payables fell 74.27% year-over-year to $337240.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $337240.0 (down 74.27% YoY) and the FY2025 annual result came in at $337240.0, down 74.27% from the prior year.
- Dividends payables fell to $337240.0 in Q4 2025, from $1.6 million in the prior quarter.
- In the past five years, Dividends payables ranged from a high of $1.6 million in Q3 2025 to a low of $66144.0 in Q1 2024.
- A 5-year average of $464259.2 and a median of $231045.0 in 2021 frame the typical range for Dividends payables.
- The widest YoY moves for Dividends payables: up 2004.26% in 2025, down 74.27% in 2025.
- Tracing GRDX's Dividends payables over 5 years: stood at $465361.0 in 2021, then jumped by 63.63% to $761488.0 in 2022, then jumped by 40.46% to $1.1 million in 2023, then climbed by 22.53% to $1.3 million in 2024, then sank by 74.27% to $337240.0 in 2025.
- The last three Dividends payables figures came in at $337240.0 (Q4 2025), $1.6 million (Q3 2025), and $163428.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | GridAI Technologies | 6.09 Mn | 6.09 Mn | - | 1.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 337,240.00 |
| Sep 30, 2025 | 1.56 Mn |
| Jun 30, 2025 | 163,428.00 |
| Mar 31, 2025 | 1.39 Mn |
| Dec 31, 2024 | 1.31 Mn |
| Sep 30, 2024 | 188,834.00 |
| Jun 30, 2024 | 104,202.00 |
| Mar 31, 2024 | 66,144.00 |
| Dec 31, 2023 | 1.07 Mn |
| Sep 30, 2023 | 231,047.00 |
| Jun 30, 2023 | 181,755.00 |
| Mar 31, 2023 | 87,431.00 |
| Dec 31, 2022 | 761,488.00 |
| Sep 30, 2022 | 298,195.00 |
| Jun 30, 2022 | 187,917.00 |
| Mar 31, 2022 | 90,792.00 |
| Dec 31, 2021 | 465,361.00 |
| Sep 30, 2021 | 349,132.00 |
| Jun 30, 2021 | 231,043.00 |
| Mar 31, 2021 | 204,382.00 |